Cite

HARVARD Citation

    Gedeborg, R. et al. (2022). Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. Acta oncologica. pp. 328-332. [Online]. 
  
Back to record